eCancer
Verified
Online/Digital
ecancer is a UK charity, working tirelessly to ensure current knowledge is properly shared. Our mission is to raise the standards of global cancer care through education. Source
Actions
Media Outlet details
| Scope | International |
|---|---|
| Language | English |
| Country | United Kingdom |
|
Similarweb UVM |
Request pricing |
|
Comscore UVM |
Request pricing |
Recent Articles
Search ArticlesWorld Cancer Congress 2026
ecancer travels so that you don't have to. Explore the latest conference coverage in global oncology and find out where we are going next. Share : Hong Kong Convention and Exhibition Centre (HKCEC), Wan Chai, China, Hong Kong Special Administrative Region Committed to working together, sharing knowledge, and forging international partnerships to improve health equity and reduce the burden of cancer around the world.
New study challenges “obesity paradox” in lung cancer, points to suppressed airway immunity
In a recent study of more than a thousand individuals, greater adiposity, or excessive body fat or fatty tissue, specifically in the abdomen, was associated with lung cancer. These findings and complementary laboratory studies published in the Journal of Thoracic Oncology suggest obesity may create an immunosuppressive environment in the lungs that allows emerging cancer cells to escape immune surveillance. JTO is the official journal of the International Association for the Study of Lung Cancer.
Current age-based genetic testing in patients with cancer may miss majority of inherited gene variants
Universal germline genetic testing of nearly 40,000 patients with solid tumours detected a substantial proportion of inherited gene variants that would have been missed by the standard germline testing approach that excludes those over age 50. This study was published in Cancer Discovery, a journal of the American Association for Cancer Research (AACR). Zsofia K. Stadler, MD, and Luis A. Diaz, Jr., MD, FAACR are the two co-corresponding authors.
Atezolizumab with fluoropyrimidine and oxaliplatin approved by FDA for the adjuvant treatment of stage III colon cancer with dMMR
The Alliance for Clinical Trials in Oncology (Alliance) today announced that the U.S. Food and Drug Administration has approved the immunotherapy drug atezolizumab (Tecentriq®) in combination with fluoropyrimidine and oxaliplatin chemotherapy, for the adjuvant treatment of patients with stage III colon cancer with deficient deoxyribonucleic acid (DNA) mismatch repair (dMMR).
Study finds automated breast ultrasound is an effective alternative to handheld ultrasound for breast cancer screening
A new study in the Journal of the American College of Radiology, published by Elsevier, has found that automated breast ultrasound (ABUS) and handheld ultrasound (HHUS) had similar cancer detection rates in women with dense breasts, while ABUS had a lower false-positive rate. It demonstrates that ABUS is a viable alternative to HHUS and can expand supplemental ultrasound screening capacity at radiology clinics.
Aspirin rarely used for colorectal cancer prevention
According to international studies, taking Acetylsalicylic acid daily can protect people with Lynch syndrome from developing colorectal cancer – even at low doses. Researchers from the University Hospital Bonn (UKB), the University of Bonn, and the Centre for Integrated Oncology (CIO) Bonn, in collaboration with the self-help organisation SemiColon, have now found that these scientific findings have so far been insufficiently incorporated into clinical practice.
Researchers identify aggressive molecular features in low-risk prostate cancer
Researchers identify aggressive molecular features in low-risk prostate cancer - ecancer
Epstein–Barr virus in paediatric sporadic Burkitt lymphoma: real-world experience from a Peruvian national referral centre
Introduction: Burkitt lymphoma (BL) is an aggressive B-cell lymphoma, representing 30%–40% of childhood non-Hodgkin lymphomas globally. In Peru, Epstein–Barr virus (EBV) is highly prevalent in lymphomas, yet its role in paediatric BL remains underexplored.
Temporal trends and high mortality of tumour lysis syndrome in gastrointestinal cancers: a national inpatient study, 2017–2022
How likely is this article to improve patient care in your region? Is reading this article likely to improve your clinical practice? How likely are you to recommend this article to a colleague?
Epstein–Barr virus in paediatric sporadic Burkitt lymphoma: real-world experience from a Peruvian national referral centre
How likely is this article to improve patient care in your region? Is reading this article likely to improve your clinical practice? How likely are you to recommend this article to a colleague?